SciClone Pharmaceuticals Inc (NASDAQ:SCLN)

8.93
Delayed Data
As of 3:49pm ET
 +0.245 / +2.82%
Today’s Change
4.24
Today|||52-Week Range
9.65
+1.88%
Year-to-Date
No recent news for SciClone Pharmaceuticals Inc.

Today’s Trading

Previous close8.68
Today’s open8.79
Day’s range8.60 - 9.03
Volume308,964
Average volume (3 months)343,869
Market cap$434.5M
Dividend yield--
Data as of 3:49pm ET, 03/30/2015

Growth & Valuation

Earnings growth (last year)+140.00%
Earnings growth (this year)+18.75%
Earnings growth (next 5 years)+14.70%
Revenue growth (last year)+6.09%
P/E ratio18.7
Price/Sales3.33
Price/Book--

Competitors

 Today’s
change
Today’s
% change
DRNADicerna Pharmaceutic...-0.78-3.25%
PRTKParatek Pharmaceutic...-0.52-1.71%
SRNESorrento Therapeutic...-0.92-7.49%
ASNDAscendis Pharma A/S-0.24-1.35%
Data as of 3:49pm ET, 03/30/2015

Financials

Next reporting dateMay 12, 2015
EPS forecast (this quarter)$0.10
Annual revenue (last year)$134.8M
Annual profit (last year)$25.2M
Net profit margin18.70%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Friedhelm Blobel
Chief Financial Officer &
Senior Vice President
Wai-Shun Wilson Cheung
Corporate headquarters
Foster City, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account